As filed with the Securities and Exchange Commission on February 9, 2026 Registration No. 333-[_] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENVERIC BIOSCIENCES, INC. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 95-4484725 (I.R.S. Employer Identification Number) Enveric Biosciences, Inc. 245 First Street, Riverview II, 18th Floor Camb ...

January 2026 Corporate Presentation Disclaimer This presentation (the "Presentation") has been prepared by Definium Therapeutics, Inc. (" Definium ", the "Company", "we", "our" or "us") solely for informational purposes. This Presentation does not constitute an offering o f, or a solicitation of an offer to purchase, securities of Definium and under no circumstances is it to be construed as a prospectus or advertisement or public offering of securities. Any trade ma rks included herein are the property of t ...